School of Nursing and Health Sciences
Permanent URI for this collection
Browse
Browsing School of Nursing and Health Sciences by Subject "depression"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item Effects of COVID-19 on Depression Symptoms in the Adult Population(2022-04-03) Page, ShariThe recent coronavirus pandemic of 2019 (COVID-19) is causing increased isolation because of quarantines and social isolation. Job loss has caused worry about whether one can pay bills and meet the necessities of life. COVID-19 has affected everyone at some level. Understanding the effects it has on a patient's mental health is essential. Ozdin and Ozdin (2020) “state women and individuals with previous mental illnesses are most affected by the COVID-19 pandemic.” This study measured depression, anxiety, and health anxiety levels during the pandemic. Chew et al. (2020) “studied psychosocial responses of the general population towards previous severe acute respiratory syndrome epidemics.” Common themes were found: anxiety, fear, depression, anger, guilt, grief, and loss. The takeaway is focus needs placed on awareness of psychosocial needs and access to psychological help during the COVID-19 outbreak. This evidence-based project (EBP) aims to identify the effect COVID-19 has had on symptoms of depression in the adult population. Participants were each given a Patient Health Questionnaire-9 (PHQ-9) and quantitative survey at their initial visit. Current patients of family practice, age 18 and older, were invited to participate in this evidence-based project (EBP), and informed consent will be signed that outlines the project. Participants received a follow-up call six weeks later. During this call, participants received the PHQ-9 questionnaire again, and a survey was constructed to determine the benefit of the handout. Their pre-COVID PHQ-9 was compared with their current PHQ-9 to determine the effects of COVID-19 on trending depressive symptoms in this population. This study analyzed survey trend results to understand better the long-term mental health effects of COVID-19 on the adult population. Results showed an increase in participants' PHQ-9 scores during the pandemic compared to pre-pandemic PHQ-9s. PHQ-9s are done post- intervention demonstrated guided imagery is beneficial in reducing depression. The spiritual information that participants took also showed beneficial for participants. There are few studies currently available as this is a new pandemic. This study and more like it are needed better to understand the effects of COVID-19 on mental health.Item The Role of Religion and Technology in the Treatment of Depression(2022-05-01) Stoughton, AlisonThe project regarding religion and technology in the treatment of depression is an intentional investigation of several concepts. Religion and technology have independently been found to be helpful in treatment of depression, a pervasive and major cause of disability in the United States (Apaydin et al., 2018). This evidence-based project (EBP) intends to apply these concepts to a clinical support tool for depression. An application was designed compiling various online religious media resources for personal depression support. A convenience sample of patients from a rural private practice, was collected over three months. A pretest-posttest design was utilized to measure the efficacy of this application in improving mood. The surveys include demographic indicators, categorical questions, and the standardized Patient Health Questionnaire (PHQ-9) for information collection. Descriptive statistics and f-tests were used to analyze the data collected for improvement in the subjective experience of depression. This was measured through three objectives: the PHQ-9 score, self-reported improvement in symptoms, and self-reported desire to continue using the application. The difference between the mean PHQ-9 score on the pre-test and post-test is 2.39 (P=0.0951), demonstrating some improvement in scores. The two-tailed f-test suggests that this difference is not statistically significant. Participants reported that 48% noticed an improvement in their symptoms with use of this application for a month. This falls short of the benchmark of >50%. Participants also reported that 64% of them are likely to continue to use this application. This measure exceeded the benchmark set for success of >50%. The outcomes reflect minimal benefit with the intervention though sample size and study design suggest caution with generalization of these results.